Alembic Pharmaceuticals (BOM:533573) PEG Ratio: N/A (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:533573 Alembic Pharmaceuticals Ltd BOM:533573
75 GF Score
Price ₹796.50
GF Value ₹1,054.87
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alembic Pharmaceuticals PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Alembic Pharmaceuticals's PE Ratio without NRI is 21.63. Alembic Pharmaceuticals's 5-Year EBITDA growth rate is -3.00%. Therefore, Alembic Pharmaceuticals's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Alembic Pharmaceuticals's PEG Ratio or its related term are showing as below:


During the past 13 years, Alembic Pharmaceuticals's highest PEG Ratio was 35.53. The lowest was 0.73. And the median was 1.21.


BOM:533573's PEG Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.71
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Alembic Pharmaceuticals  (BOM:533573) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Alembic Pharmaceuticals PEG Ratio Related Terms


Alembic Pharmaceuticals PEG Ratio Historical Data

* Premium members only.

The historical data trend for Alembic Pharmaceuticals's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alembic Pharmaceuticals PEG Ratio Chart

Alembic Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.39 0.00 0.00 0.00 27.45

Alembic Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 27.45

BOM:533573 vs ZTS, UTHR: PEG Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alembic Pharmaceuticals's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alembic Pharmaceuticals PEG Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alembic Pharmaceuticals's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Alembic Pharmaceuticals's PEG Ratio falls into.


BOM:533573
75GF Score
Alembic Pharmaceuticals Ltd BOM:533573
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alembic Pharmaceuticals PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Alembic Pharmaceuticals's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=21.626391528645/-3.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Alembic Pharmaceuticals (BOM:533573) Overvalued in 2026?

Based on GuruFocus' analysis, Alembic Pharmaceuticals stock appears to be undervalued. The current stock price of ₹796.50 is trading 24.5% below its estimated GF Value™ of ₹1,054.87. GuruFocus considers Alembic Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for BOM:533573:

  • PEG Ratio: N/A
  • GF Value™: ₹1,054.87 vs. price of ₹796.50 (24.5% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the BOM:533573 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alembic Pharmaceuticals Business Description

Other Exchanges APLLTD:India
Address Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities.
75GF Score

Get the complete analysis for BOM:533573

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹796.50
Price
₹1,054.87
GF Value